Who owns Sellas Life Sciences Group I?
- Ticker: SLS
- CUSIP Number: 81642t209
Tip: Access positions for across all investors
Analyze quarterly positions in Sellas Life Sciences Group I with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Sellas Life Sciences Group I stock
Who bought or sold Sellas Life Sciences Group I this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 1.5M | $1.5M | 32% | Mar 2024 |
|
| Susquehanna International | 1.4M | $1.4M | 1079% | Mar 2024 |
|
| Alyeska Investment Group | 1.0M | $1.0M | -22% | Mar 2024 |
|
| BlackRock | 278k | $281k | -1% | Mar 2024 |
|
| Geode Capital Management | 273k | $276k | 16% | Mar 2024 |
|
| Opus Capital Group | 201k | $203k | 49% | Mar 2024 |
|
| Citadel Advisors | 169k | $170k | -40% | Mar 2024 |
|
| Northern Trust | 89k | $91k | 125% | Mar 2024 |
|
| Virtu Financial | 60k | $64k | 216% | Dec 2023 |
|
| Prosperity Financial Group | 25k | $26k | 2% | Mar 2024 |
|
| Mariner Wealth Advisors | 25k | $26k | 100% | Mar 2024 |
|
| Cantor Fitzgerald, L. P. | 25k | $25k | 100% | Mar 2024 |
|
| Tower Research Capital | 21k | $21k | 130% | Mar 2024 |
|
| XTX Topco | 17k | $18k | -47% | Mar 2024 |
|
| Charles Schwab Investment Management | 16k | $16k | 0% | Mar 2024 |
|
| Commonwealth Equity Services | 14k | $14k | 13% | Mar 2024 |
|
| Brooklyn FI | 11k | $11k | 100% | Mar 2024 |
|
| Nemes Rush Group | 10k | $10k | 0% | Mar 2024 |
|
| Jpmorgan Chase & Co | 6.1k | $6.2k | -38% | Mar 2024 |
|
| Advisor Group Holdings | 1.7k | $1.7k | 0% | Mar 2024 |
|
| Morgan Stanley | 1.4k | $1.4k | -41% | Mar 2024 |
|
| Wells Fargo & Company | 301.00 | $304.010000 | -98% | Mar 2024 |
|
| Royal Bank of Canada | 223.00 | $0 | -38% | Mar 2024 |
|
| Hanson McClain Advisors | 150.00 | $151.995000 | 0% | Mar 2024 |
|
| JJJ Advisors | 11.00 | $11.999900 | 0% | Mar 2024 |
|
| Parkside Financial Bank & Trust | 2.00 | $3.000000 | 0% | Mar 2024 |
|
| Qube Research & Technologies | 2.00 | $2.000000 | 0% | Mar 2024 |
|
| FMR | 1.00 | $1.000000 | 100% | Mar 2024 |
|
Who sold out of Sellas Life Sciences Group I?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Bank of New York Mellon | Dec 2023 | 85k | $90k |
| Two Sigma Securities | Dec 2023 | 15k | $16k |
| Millennium Management | Dec 2023 | 11k | $12k |
| Bank of America Corporation | Dec 2023 | 42.00 | $43.999200 |